WO1996006846A1 - Nouveaux derives d'aryle piperazines - Google Patents
Nouveaux derives d'aryle piperazines Download PDFInfo
- Publication number
- WO1996006846A1 WO1996006846A1 PCT/ES1995/000094 ES9500094W WO9606846A1 WO 1996006846 A1 WO1996006846 A1 WO 1996006846A1 ES 9500094 W ES9500094 W ES 9500094W WO 9606846 A1 WO9606846 A1 WO 9606846A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyano
- trifluoromethyl
- amino
- bromo
- compound according
- Prior art date
Links
- 0 *C**1/N=C/C**CC1 Chemical compound *C**1/N=C/C**CC1 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Definitions
- the present invention concerns new compounds of general formula JL where X is - (CH 2 ) 3 - or - (CH 2 ) 4 -; m is equal to 0 or 1; n is equal to 1, 2, 3 or 4; Ar is 1-naphthyl, 7-benzofuranyl, 2,3-dihydro-l, 4-benzodioxan-5-yl, 3,4-dihydro-2i-l, 5-benzodioxepin-6-yl, phenyl or alkyl substituted phenyl , halogen, trifluoromethyl, nitro, cyano, alkoxy, amino, alkylcarbamoyl, alkylsulfonamido or alkoxycarbonyl.
- 5-HT 1A receptor agonists play in controlling anxiety and depression (M. Hamon, Trends Pharmacol. Sci. 1994, 15, 36; P. Blier and C. Montigny, Trends Pharmacol. Sci. 1994, 15, 220). So far, the only 5-HT agonist, A marketed is buspirone. However, this drug lacks specificity on said receptor, since it is capable of binding to other types of receptors (dopaminergic, ⁇ -yo adrenergic, ⁇ -aminobutyric acid (GABA) -benzodiazepines and muscarinic).
- GABA ⁇ -aminobutyric acid
- the present invention relates to new arylpiperazine derivatives, which have shown a high affinity for the 5-HT, A receptor.
- the new arylpiperazine derivatives are represented by the general formula I:
- X is - (CH 2 ) 3 - or - (CH 2 ) 4 -; m is equal to 0 or 1; n is equal to 1, 2, 3 or 4
- R 1 , R 2 and R 3 is hydrogen, alkyl, halogen tri-fluoromethyl, nitro, cyano, alkoxy, amino, alkylcarbamoyl, alkylsulfonamido or alkoxycarbonyl
- Non-commercial 1-arylpiperazines have been obtained according to the methods described in the literature: J. A. Chem. Soc, 76, 1853 (1954); J. Med. Chem., 32, 1052 (1989); JP61, 152,655; J. Med. Chem., 31, 1934 (1988).
- the starting products of formula m are obtained by treating the L-proline or ethyl pipecolinate with 2-chloroethyl isocyanate.
- affinities of some of the compounds of general structure I by the serotonergic 5-HT 1A receptor in rat cerebral cortex membranes were determined by radioligand techniques using 3 H-8-OH-DPAT [8-hydroxy-2- (di -n-propylamino) tetralin] with selective ligand.
- mice Male albino rats (Rattus norvegicus albimts), Sprague-Dawley breed, weighing approximately 200 g, are sacrificed by decapitation. Brains are quickly removed and frozen in liquid nitrogen. The tissue is stored at -40 ° C until it is used.
- the cerebral cortex is homogenized in 10 volumes of 50 mM Tris-HCl buffer, pH 7, at 25 ° C and centrifuged at 28000 x g for 15 min, at 4 ° C. The supernatant is neglected and sediment is washed twice by resuspension and centrifugation under the conditions described.
- the resuspended sediment is incubated at 37 ° C for 10 min.
- the membranes are centrifuged again and the pellet is resuspended in 10 volumes of Tris-HCl buffer with 5 mM MgSO 4 and 0.5 mM NajEDTA (pH 7.4 at 25 ° C).
- Fractions of 100 ⁇ l of the final suspension of the membranes (5 mg / ml protein) are incubated for 10 min at 37 ° C with 3 H 8-OH-DPAT 0.6 nM in the presence or absence of the compound under study in an end volume of 1.1 ml of 50 mM Tris-HCl buffer, pH 7.4.
- Non-specific binding is determined with 10 ⁇ M serotonin.
- the bound radioactive ligands are separated from the free ones by vacuum filtration on Whatman GF / B filter washed twice with 4 ml of 50 M Tris-HCl buffer, pH 7.4 at 4 ° C. After sec the filters for one hour at 60 ° C, 4 ml of scintillation liquid (Aquasol) are added and the radioactivity bound to the membranes is measured by liquid scintillation spectrometry.
- Whatman GF / B filter washed twice with 4 ml of 50 M Tris-HCl buffer, pH 7.4 at 4 ° C. After sec the filters for one hour at 60 ° C, 4 ml of scintillation liquid (Aquasol) are added and the radioactivity bound to the membranes is measured by liquid scintillation spectrometry.
- Aquasol scintillation liquid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne de nouveaux composés de formule générale (I), dans laquelle X représente -(CH2)3-O-(CH2)4-; m est égal à 0 ou 1; n est égal à 1, 2, 3 ou 4; Ar représente 1-naphthyle, 7-benzofuranyle, 2,3-dihidro-1,4-benzodioxane-5-yle, 3,4-dihydro-2H-1,5-benzodioxépine-6-yle, phényle ou phényle substitué par alkyle, halogène, trifluorométhyle, nitro, cyano, alcoxy, amino, alkylcarbamyle, alkylsulfonamido ou alcoxy carbonylo. L'invention concerne également les différents procédés de préparation de ces composés, lesquels présentent une affinité pour le récepteur sérotoninergique 5-HT1A, mettant en évidence son utilité du point de vue thérapeutique dans le traitement des troubles du SNC, tels que l'anxiété et la dépression.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU30792/95A AU3079295A (en) | 1994-09-01 | 1995-07-28 | New arylpiperazine derivatives |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ESP9401895 | 1994-09-01 | ||
ES9401895A ES2082727B1 (es) | 1994-09-01 | 1994-09-01 | Nuevos derivados de arilpiperazinas. |
ES9501534A ES2095811B1 (es) | 1995-07-28 | 1995-07-28 | Nuevos derivados de arilpiperazinas. |
ESP9501534 | 1995-07-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996006846A1 true WO1996006846A1 (fr) | 1996-03-07 |
Family
ID=26154819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES1995/000094 WO1996006846A1 (fr) | 1994-09-01 | 1995-07-28 | Nouveaux derives d'aryle piperazines |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3079295A (fr) |
WO (1) | WO1996006846A1 (fr) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015527A1 (fr) * | 1997-09-23 | 1999-04-01 | Universidad Complutense De Madrid | PROCEDE D'OBTENTION DU 2-[4-[4-(m- ETHYLSULFONAMIDOPHENYL) PIPERAZINE-1-YL] BUTYL]-1,3- DIOXOPERHYDROPYRROLO [1,2-c]IMIDAZOL |
ES2154605A1 (es) * | 1999-09-14 | 2001-04-01 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
EP1674103A1 (fr) * | 2004-12-27 | 2006-06-28 | Cepa Schwarz Pharma s.l. | Dérivés d'arylpiperazines et leurs utilisations en tant que ligands du récepteur 5-HT1A |
US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
US7351732B2 (en) | 2002-07-31 | 2008-04-01 | Schwarz Pharma S.L. | Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications |
US7459473B2 (en) | 1998-06-03 | 2008-12-02 | Glia Med, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
WO2023135528A1 (fr) | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | Dérivés hétéroalicycliques et leur utilisation dans le traitement de troubles du snc |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2092785A1 (en) * | 1970-06-18 | 1972-01-28 | Hokuriku Pharmaceutical | 2-azaquinolizidine derivs and salts neurotropic and anti - -histamine agents synthesis |
US3717634A (en) * | 1969-11-24 | 1973-02-20 | Mead Johnson & Co | N-(heteroarcyclic)piperazinylalkyl-azaspiroalkanediones |
EP0256936A1 (fr) * | 1986-08-12 | 1988-02-24 | Rhone-Poulenc Sante | Nouveaux dérivés de la benzyl-4 pipérazine, leur préparation et les compositions pharmaceutiques qui les contiennent |
EP0296048A1 (fr) * | 1987-06-15 | 1988-12-21 | Adir Et Compagnie | Nouveaux dérivés de la pipérazinyl alkyl piperazine dione, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent |
EP0362555A1 (fr) * | 1988-09-03 | 1990-04-11 | Hoechst Aktiengesellschaft | Pipérazinediones à activité psychotrope |
-
1995
- 1995-07-28 AU AU30792/95A patent/AU3079295A/en not_active Abandoned
- 1995-07-28 WO PCT/ES1995/000094 patent/WO1996006846A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3717634A (en) * | 1969-11-24 | 1973-02-20 | Mead Johnson & Co | N-(heteroarcyclic)piperazinylalkyl-azaspiroalkanediones |
FR2092785A1 (en) * | 1970-06-18 | 1972-01-28 | Hokuriku Pharmaceutical | 2-azaquinolizidine derivs and salts neurotropic and anti - -histamine agents synthesis |
EP0256936A1 (fr) * | 1986-08-12 | 1988-02-24 | Rhone-Poulenc Sante | Nouveaux dérivés de la benzyl-4 pipérazine, leur préparation et les compositions pharmaceutiques qui les contiennent |
EP0296048A1 (fr) * | 1987-06-15 | 1988-12-21 | Adir Et Compagnie | Nouveaux dérivés de la pipérazinyl alkyl piperazine dione, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent |
EP0362555A1 (fr) * | 1988-09-03 | 1990-04-11 | Hoechst Aktiengesellschaft | Pipérazinediones à activité psychotrope |
Non-Patent Citations (1)
Title |
---|
R. PERRONE ET AL.: "Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphtalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationships", JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 1, WASHINGTON US, pages 99 - 104 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999015527A1 (fr) * | 1997-09-23 | 1999-04-01 | Universidad Complutense De Madrid | PROCEDE D'OBTENTION DU 2-[4-[4-(m- ETHYLSULFONAMIDOPHENYL) PIPERAZINE-1-YL] BUTYL]-1,3- DIOXOPERHYDROPYRROLO [1,2-c]IMIDAZOL |
ES2129370A1 (es) * | 1997-09-23 | 1999-06-01 | Univ Madrid Complutense | Procedimiento para la obtencion del 2-(4-(4-(m-etilsulfonamidofenil)p iperazin-1-il(butil)-1,3-dioxoperhidropirrolo)1,2-c(imidazol |
US7459473B2 (en) | 1998-06-03 | 2008-12-02 | Glia Med, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
ES2154605A1 (es) * | 1999-09-14 | 2001-04-01 | Univ Madrid Complutense | Nuevos derivados mixtos de bencimidazol-arilpiperazina con afinidad por los receptores serotoninergicos 5-ht1a y 5-ht3 |
US6417189B1 (en) | 1999-11-12 | 2002-07-09 | Gpi Nil Holdings, Inc. | AZA compounds, pharmaceutical compositions and methods of use |
US7253169B2 (en) | 1999-11-12 | 2007-08-07 | Gliamed, Inc. | Aza compounds, pharmaceutical compositions and methods of use |
US7351732B2 (en) | 2002-07-31 | 2008-04-01 | Schwarz Pharma S.L. | Cycloalkanedione derivatives, method for the production thereof and their pharmacological applications |
EP1674103A1 (fr) * | 2004-12-27 | 2006-06-28 | Cepa Schwarz Pharma s.l. | Dérivés d'arylpiperazines et leurs utilisations en tant que ligands du récepteur 5-HT1A |
WO2006069993A1 (fr) * | 2004-12-27 | 2006-07-06 | Schwarz Pharma S.L. | Derives d’arylpiperazine et leur utilisation comme ligands du recepteur as 5-ht1a |
WO2023135528A1 (fr) | 2022-01-11 | 2023-07-20 | Suven Life Sciences Limited | Dérivés hétéroalicycliques et leur utilisation dans le traitement de troubles du snc |
Also Published As
Publication number | Publication date |
---|---|
AU3079295A (en) | 1996-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2246399T3 (es) | 1,2,3,4-tetrahidroisoquinolinas como antagonistas derivados del receptor de urotensina ii. | |
JP2721147B2 (ja) | α1−アドレナリン受容体拮抗剤としてのピリミジンジオン、ピリミジントリオン、トリアジンジオン、テトラヒドロキナゾリンジオン誘導体 | |
US6787535B2 (en) | Indole derivatives with 5HT6 receptor affinity | |
RU2028297C1 (ru) | Производные пиримидин-4-она или их фармацевтически приемлемые соли и серотонинантагонистическая, допаминантагонистическая и антигистаминная композиция на их основе | |
CA2051697C (fr) | Amines heterocycliques ayant une activite sur le systeme nerveux central | |
CA2012628C (fr) | Nouveaux derives fluoro-4 benzoiques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent | |
Chern et al. | Studies on quinazolines. 5. 2, 3-Dihydroimidazo [1, 2-c] quinazoline derivatives: a novel class of potent and selective. alpha. 1-adrenoceptor antagonists and antihypertensive agents | |
CA2334970A1 (fr) | Inhibiteurs quinazolinone de la phosphodiesterase cgmp | |
AU2002310747A1 (en) | New indole derivatives with 5-HT6 receptor affinity | |
PL191489B1 (pl) | Pochodna 2-arylo-8-oksodihydropuryny, sposób jej wytwarzania i jej zastosowanie, zawierająca ją kompozycja farmaceutyczna, zawierający ją środek do leczenia oraz zawierający ją środek przeciwlękowy | |
CZ294493B6 (cs) | Deriváty benzimidazolu, způsob jejich přípravy a léčebné prostředky s jejich obsahem | |
RU2118322C1 (ru) | 2,3-дигидро-1,4-бензодиокси-5-ил-пиперазиновые производные или их соли | |
HU198931B (en) | Process for producing 2-square brackets open /piperidin-4-yl/-methyl square brackets closed -1,2,3,4-tetradihydro-9h-pyrido/3,4-b/indole derivatives and pharma ceutical compositions comprising same | |
AU4376897A (en) | Novel indole-2,3-dione-3-oxime derivatives | |
AU721102B2 (en) | 1H-pyrido{3,4-b}indole-4-carboxamide derivatives, their preparation and their application in therapeutics | |
AU675880B2 (en) | 1(2H-1-benzopyran-2-one-8-yl)-piperazine derivatives | |
US6821984B2 (en) | Ring fused pyrazole derivatives as CRF antagonists | |
US7491729B2 (en) | 3-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereof | |
US5919788A (en) | 4-(1H-indol-1-yl)-1-piperidinyl derivatives | |
WO1996006846A1 (fr) | Nouveaux derives d'aryle piperazines | |
CZ290011B6 (cs) | Deriváty 4-oxo-3,5dihydro-4H-pyridazino[4,5-b]indol-1-acetamidu a farmaceutický prostředek, který je obsahuje | |
JP2009500304A (ja) | アシッドポンプアンタゴニストとしてのイミダゾピリジン誘導体 | |
FI92203B (fi) | Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi | |
NO172437B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser | |
US5466706A (en) | 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |